Alumis Inc. ALMS
We take great care to ensure that the data presented and summarized in this overview for ALUMIS INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ALMS
Top Purchases
Top Sells
About ALMS
Insider Transactions at ALMS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2024
|
James B. Tananbaum Director |
BUY
Open market or private purchase
|
Indirect |
2,500,000
+19.77%
|
$40,000,000
$16.0 P/Share
|
|
Jul 01
2024
|
James B. Tananbaum Director |
BUY
Conversion of derivative security
|
Indirect |
11,476,484
+32.61%
|
-
|
|
Jul 01
2024
|
Foresite Capital Management V, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,500,000
+19.77%
|
$40,000,000
$16.0 P/Share
|
|
Jul 01
2024
|
Foresite Capital Management V, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
11,476,484
+32.61%
|
-
|
|
Jul 01
2024
|
Foresite Labs, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,500,000
+19.77%
|
$40,000,000
$16.0 P/Share
|
|
Jul 01
2024
|
Foresite Labs, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
11,476,484
+32.61%
|
-
|
|
Jul 01
2024
|
Ayur Maya Capital Management Company, LP Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,500,000
+19.02%
|
$40,000,000
$16.0 P/Share
|
|
Jul 01
2024
|
Ayur Maya Capital Management Company, LP Director |
BUY
Conversion of derivative security
|
Indirect |
8,145,966
+50.0%
|
-
|
|
Jul 01
2024
|
Sara Klein General Counsel - Corp Secy |
BUY
Grant, award, or other acquisition
|
Direct |
33,796
+50.0%
|
-
|
|
Jul 01
2024
|
Sara Klein General Counsel - Corp Secy |
SELL
Sale (or disposition) back to the issuer
|
Direct |
33,796
-100.0%
|
-
|
|
Jul 01
2024
|
Srinivas Akkaraju |
BUY
Grant, award, or other acquisition
|
Indirect |
1,703,998
+50.0%
|
-
|
|
Jul 01
2024
|
Srinivas Akkaraju |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,703,998
-100.0%
|
-
|
|
Jul 01
2024
|
Srinivas Akkaraju |
BUY
Conversion of derivative security
|
Indirect |
1,703,998
+50.0%
|
-
|
|
Jul 01
2024
|
Zhengbin Yao |
BUY
Grant, award, or other acquisition
|
Direct |
23,529
+50.0%
|
-
|
|
Jul 01
2024
|
Zhengbin Yao |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,529
-100.0%
|
-
|
|
Jul 01
2024
|
Martin Babler President, CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Indirect |
90,804
+50.0%
|
-
|
|
Jul 01
2024
|
Martin Babler President, CEO and Chairman |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
90,804
-100.0%
|
-
|
|
Jul 01
2024
|
Mark Christopher Bradley Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
40,052
+50.0%
|
-
|
|
Jul 01
2024
|
Mark Christopher Bradley Chief Development Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
40,052
-100.0%
|
-
|
|
Jul 01
2024
|
Mark Christopher Bradley Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,978
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
56.6M
Shares
From
16
Insiders
| Conversion of derivative security | 44.3M shares |
|---|---|
| Open market or private purchase | 7.5M shares |
| Grant, award, or other acquisition | 4.81M shares |
Sell / Disposition
2.31M
Shares
From
7
Insiders
| Sale (or disposition) back to the issuer | 2.31M shares |
|---|